1
|
Alström CH, Hallgren B, Nilsson LB and
Asander H: Retinal degeneration combined with obesity, diabetes
mellitus and neurogenous deafness: a specific syndrome (not
hitherto described) distinct from the Laurence-Moon-Bardet-Biedl
syndrome: a clinical, endocrinological and genetic examination
based on a large pedigree. Acta Psychiatr Neurol Scand Suppl.
129:3271–35. 1959.
|
2
|
Marshall JD, Beck S, Maffei P and Naggert
JK: Alström syndrome. Eur J Hum Genet. 15:1193–1202. 2007.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Marshall JD, Bronson RT, Collin GB,
Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S,
Russell-Eggitt I, Shea SE, et al: New Alström syndrome phenotypes
based on the evaluation of 182 cases. Arch Intern Med. 165:675–683.
2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hearn T, Renforth GL, Spalluto C, Hanley
NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF,
Russell-Eggitt I, et al: Mutation of ALMS1, a large gene with a
tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat
Genet. 31:79–83. 2002. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Collin GB, Marshall JD, Cardon LR and
Nishina PM: Homozygosity mapping at Alström syndrome to chromosome
2p. Hum Mol Genet. 6:213–219. 1997. View Article : Google Scholar : PubMed/NCBI
|
6
|
Marshall JD, Hinman EG, Collin GB, Beck S,
Cerqueira R, Maffei P, Milan G, Zhang W, Wilson DI, Hearn T, et al:
Spectrum of ALMS1 variants and evaluation of genotype-phenotype
correlations in Alström syndrome. Hum Mutat. 28:1114–1123. 2007.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Collin GB, Marshall JD, King BL, Milan G,
Maffei P, Jagger DJ and Naggert JK: The Alström syndrome protein,
ALMS1, interacts with α-actinin and components of the endosome
recycling pathway. PLoS One. 7:e379252012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hearn T: ALMS1 and Alström syndrome: A
recessive form of metabolic, neurosensory and cardiac deficits. J
Mol Med (Berl). 97:1–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al ACMG
laboratory quality assurance committee, : Standards and guidelines
for the interpretation of sequence variants: A joint consensus
recommendation of the American College of Medical Genetics and
Genomics and the Association for Molecular Pathology. Genet Med.
17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang J, Chen L, Zhou C, Wang L, Xie H,
Xiao Y, Zhu H, Hu T, Zhang Z, Zhu Q, et al: Prospective chromosome
analysis of 3429 amniocentesis samples in China using copy number
variation sequencing. Am J Obstet Gynecol. 219:287.e1–287.e18.
2018. View Article : Google Scholar
|
12
|
Beck TF, Mullikin JC; NISC Comparative
Sequencing Program, ; Biesecker LG: Systematic evaluation of Sanger
validation of next-generation sequencing variants. Clin Chem.
62:647–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Casey J, McGettigan P, Brosnahan D, Curtis
E, Treacy E, Ennis S and Lynch SA: Atypical Alstrom syndrome with
novel ALMS1 mutations precluded by current diagnostic criteria. Eur
J Med Genet. 57:55–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Russell-Eggitt IM, Clayton PT, Coffey R,
Kriss A, Taylor DS and Taylor JF: Alström syndrome. Report of 22
cases and literature review. Ophthalmology. 105:1274–1280. 1998.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Waldman M, Han JC, Reyes-Capo DP, Bryant
J, Carson KA, Turkbey B, Choyke P, Naggert JK, Gahl WA, Marshall
JD, et al: Alström syndrome: Renal findings in correlation with
obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38
patients prospectively evaluated at the NIH clinical center. Mol
Genet Metab. 125:181–191. 2018. View Article : Google Scholar : PubMed/NCBI
|
16
|
Collin GB, Marshall JD, Ikeda A, So WV,
Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin
M, et al: Mutations in ALMS1 cause obesity, type 2 diabetes and
neurosensory degeneration in Alström syndrome. Nat Genet. 31:74–78.
2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Marshall JD, Maffei P, Collin GB and
Naggert JK: Alström syndrome: Genetics and clinical overview. Curr
Genomics. 12:225–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Pulignani S, Vecoli C, Borghini A, Foffa
I, Ait-Alì L and Andreassi MG: Targeted next-generation sequencing
in patients with non-syndromic congenital heart disease. Pediatr
Cardiol. 39:682–689. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Adams DR and Eng CM: Next-generation
sequencing to diagnose suspected genetic disorders. N Engl J Med.
379:1353–1362. 2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Marshall JD, Muller J, Collin GB, Milan G,
Kingsmore SF, Dinwiddie D, Farrow EG, Miller NA, Favaretto F,
Maffei P, et al: Alström syndrome: Mutation spectrum of ALMS1. Hum
Mutat. 36:660–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Flintoff KJ and Boute-Benejean O: Novel
human pathological mutations. Gene symbol: ALMS1. Disease: Alstrom
syndrome. Hum Genet. 121:645–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Nerakh G and Ranganath P: Alström Syndrome
presenting as isolated dilated cardiomyopathy. Indian J Pediatr.
86:296–298. 2019. View Article : Google Scholar : PubMed/NCBI
|